India's Vijaya Cannabis Gummies Navigate Narrow Legal Window
Ayurvedic cannabis products remain legal under India's NDPS Act, but THC thresholds and labeling rules create compliance minefield.
Close-up of a hand gently holding a cannabis leaf, emphasizing its lush green texture and detail.
India's NDPS Act allows cannabis leaf preparations, bans resin and flowering tops.
The Narcotic Drugs and Psychotropic Substances Act of 1985 criminalizes cannabis resin (charas) and flowering tops (ganja) but explicitly exempts preparations made from cannabis leaves when formulated as Ayurvedic, Siddha, or Unani medicines. This statutory exception lets manufacturers produce Vijaya gummies, oils, and tinctures using leaf extracts, provided they secure a license from the state Drugs Control Administration and comply with THC concentration limits set by the Ayurvedic Pharmacopoeia of India.
The distinction is technical. It's also consequential. Products derived from flowering tops or resin remain Schedule I narcotics, while leaf-based formulations are legal medicines.
THC thresholds and labeling requirements determine product legality.
Legal Vijaya products must contain THC concentrations below 0.3 percent by dry weight, according to guidelines issued by the Ministry of Ayush and enforced by state drug inspectors. Every package must display a manufacturing license number, batch number, expiration date, and a clear statement that the product is an Ayurvedic formulation, not a recreational edible. Manufacturers who exceed the THC ceiling or mislabel products face license revocation and prosecution under NDPS provisions.
Consumers can't verify THC levels in the field. The only verification method is third-party lab analysis, which few buyers commission.
Gray-market edibles exploit enforcement gaps in India's fragmented regulatory system.
Cannabis enforcement in India is split across the Central Bureau of Narcotics, state drug control departments, and local police, creating jurisdictional confusion that gray-market operators exploit. Unlicensed gummies marketed as hemp or CBD products frequently contain THC levels exceeding legal limits, yet enforcement actions remain sporadic. A September 2026 investigation by the Food Safety and Standards Authority of India found that 41 percent of sampled cannabis edibles sold online lacked valid manufacturing licenses.
For context on India's evolving cannabis framework, see the CannIntel topic hub on India Cannabis Laws.
What to watch: FSSAI rulemaking and interstate enforcement coordination.
The Food Safety and Standards Authority of India announced in August 2026 that it's drafting new regulations to govern cannabis-infused food products, including mandatory lab testing and interstate supply-chain tracking. If finalized, the rules would require all Vijaya edibles to carry QR codes linking to third-party lab certificates. Implementation depends on coordination between FSSAI, the Ministry of Ayush, and state drug controllers, a process that's historically been slow.
The next milestone: FSSAI's draft regulations are expected for public comment in November 2026.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws
State-Licensed Marijuana Operators Face Long DEA Registration Waits
A Rutland Herald report says state-licensed marijuana operators should expect long waits for DEA registrations, putting a procedural bottleneck at the center of the rescheduling debate.
Manchester, CT Rejects Public Cannabis Smoking Site
Manchester, Connecticut turned down a proposed public cannabis smoking site, a local ruling that tests how far Public Act 21-1 reaches into consumption venues.
Austin Hemp Shops Eye Texas Lt. Governor Race as THC Rules Bite
Austin retailers are tracking the November lieutenant governor election while state THC restrictions and a November federal hemp deadline reshape their inventory and legal exposure.
More from the newsroom
Report links heavy cannabis use to worse cognition in young adults
Bioengineer.org reports a study tying heavy use to cognitive deficits in young adults while suggesting mild use may help people with HIV; the underlying paper isn't yet verified.
Hall of Flowers Sets New York Return at Pier 36, Oct. 21-22
The California-born trade show brings its format to Pier 36 for two days, with access for New Yorkers who aren't on the guest list.
Newsweed Report: German Medical THC Prices Vary 12-Fold
A Newsweed report published Oct. 17 puts a 12x spread on THC pricing in Germany's medical market, raising margin and pricing-power questions for operators.